QI
BIIB icon

Quotient Investors’s Biogen BIIB Stock Holding History

Quotient Investors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$2.49M Buy
7,964
+46
+0.6% +$13.6K 1.71% 10
2017
Q2 		$2.15M Buy
7,918
+500
+7% +$132K 1.53% 12
2017
Q1 		$2.03M Sell
7,418
-140
-2% -$39.6K 1.22% 19
2016
Q4 		$2.14M Buy
7,558
+714
+10% +$212K 1.35% 15
2016
Q3 		$2.14M Sell
6,844
-1,870
-21% -$554K 1.38% 10
2016
Q2 		$2.11M Buy
8,714
+715
+9% +$188K 0.99% 25
2016
Q1 		$2.08M Buy
7,999
+696
+10% +$184K 0.76% 40
2015
Q4 		$2.24M Sell
7,303
-10,730
-60% -$3.08M 0.86% 36
2015
Q3 		$5.26M Sell
18,033
-7,654
-30% -$2.53M 1.16% 26
2015
Q2 		$10.4M Sell
25,687
-2,936
-10% -$1.18M 1.42% 20
2015
Q1 		$12.1M Buy
28,623
+13,100
+84% +$5.16M 1.63% 17
2014
Q4 		$5.27M Buy
15,523
+2,029
+15% +$656K 1.08% 23
2014
Q3 		$4.46M Buy
13,494
+4,400
+48% +$1.45M 0.97% 25
2014
Q2 		$2.87M Sell
9,094
-7,631
-46% -$2.3M 0.62% 46
2014
Q1 		$5.12M Buy
16,725
+6,470
+63% +$2.05M 1.17% 23
2013
Q4 		$2.87M Buy
10,255
+8,919
+668% +$2.31M 0.67% 48
2013
Q3 		$322K Buy
1,336
+36
+3% +$8.06K 0.08% 213
2013
Q2 		$280K Buy
+1,300
New +$278K 0.08% 210

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quotient Investors's BIIB Position: Q3 2017 in Review

Quotient Investors increased its Biogen (BIIB) stake by 0.58% in Q3 2017, buying an estimated $13.6K and bringing the position to 7,964 shares worth $2.49M. The position accounts for 1.71% of the portfolio, ranked #10.

Quotient Investors first reported a position in BIIB in Q2 2013 and has held it in 18 quarters since. The position peaked at $12.1M in Q1 2015. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Quotient Investors held 7,964 shares of Biogen worth $2.49M as of Q3 2017.
  • Quotient Investors bought 46 Biogen shares in Q3 2017, an estimated $13.6K.
  • Biogen made up 1.71% of Quotient Investors's portfolio in Q3 2017, its #10 holding.
  • Quotient Investors first reported a position in Biogen in Q2 2013 and has held it in 18 quarters since.
  • Quotient Investors's Biogen position peaked at $12.1M in Q1 2015.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.